Conference Reports for NATAP
July 23rd - 26th
12th IAS Conference on HIV Science
The REPRIEVE trial: Developing a cardiovascular
disease prevention strategy for people living with HIV -
"should be inserted in Guidelines"
IAS 2023 july 24
REPRIEVE Results published: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection